Table of Contents Table of Contents
Previous Page  484 / 1082 Next Page
Information
Show Menu
Previous Page 484 / 1082 Next Page
Page Background

S469

ESTRO 36 2017

_______________________________________________________________________________________________

Results

From the simulation of patient weight loss (thickness

reduction), Watchdog has less sensitivity to small patient

thickness reduction. From figure 1 left, it can imply that

dropping by 25% c pass-rate refers to 10% patient

thickness reduction or approximately 1.5 cm shrinkage. In

clinical case validation, Watchdog was able to detect the

significant patient anatomical changes that lead to the

decision to replan all four HN IMRT patients (see figure 1

right). Based on this study, we found that Watchdog

system can detect the clinically significant anatomical

change in HN IMRT based on 1) at least 3 out of 7 fields of

the fraction are below the SPC-based threshold, 2) the

lowest c pass-rate is less than 30%, and 3) a 25% c pass-

rate drop equates to approximately a 1.5 cm (-10.0%)

patient thickness reduction.

Conclusion

The Watchdog dosimetic response to HN patient

anatomical changes has been evaluated based on the

simulation of patient thickness reduction/weight loss and

clinical cases of HN IMRT replan. Using the SPC-based

threshold, Watchdog is able to detect clinically significant

anatomical changes in HN IMRT treatment.

PO-0869 A population-based estimate of proton beam

specific range uncertainties in the thorax

Y.Z. Szeto

1

, M.G. Witte

1

, M. Van Herk

2

, J. Sonke

1

1

Netherlands Cancer Institute Antoni van Leeuwenhoek

Hospital, Radiotherapy department, Amsterdam, The

Netherlands

2

Institute of Cancer Sciences- University of Manchester,

Molecular and Clinical Cancer Sciences, Manchester,

United Kingdom

Purpose or Objective

Proton therapy has great potential for locally advanced

lung cancer patients because of considerable reduction of

intermediate and low dose to the healthy tissues.

However, due to their finite beam range, proton dose

distributions are more susceptible to anatomical

variations. The purpose of this study was to derive a

population-based map of beam specific range

uncertainties due to anatomical variations.

Material and Methods

The planning CT (pCT) of 100 NSCLC patients treated

between 2010 and 2013 with (chemo-)radiotherapy were

included. To simulate realistic anatomical variations, we

used a previously developed statistical model, based on

principal component analysis for systematic variations in

the thorax. This model generates deformation vector

fields that deform the planning CT to induce systematic

differences between the anatomy of planning and

delivery. For each patient, we synthesized 1000 CTs (sCT)

representing plausible variations in treatment anatomy.

Subsequently, the water-equivalent path length

differences (∆R) between the pCT and sCTs was calculated

at the beam’s distal and proximal edge of the GTV for 13

equally spaced angles of 15

through the ipsilateral lung.

Undershoot and overshoot at the distal edge results in an

under-coverage of the target and higher dose in normal

tissues respectively, and vice versa at the proximal edge.

To summarize the results, first for each scan and angle,

the 95th percentile ∆R in undershoot (∆R

u

) and overshoot

(∆R

o

) was determined at the distal and proximal edge of

the tumor respectively. Secondly, for each angle and

patient, the 90th percentile of ∆R

u

and ∆R

o

were

calculated. Finally, median and inter-quartile ranges for

these beam-specific range uncertainties were evaluated.

Results

Figure 1 shows the median and inter-quartile range of ∆R

u

and ∆R

o

for the 13 different angles. For both ∆R

u

and ∆R

o,

the range errors of the lateral beams (around 90

) are

significant lower (paired T-test, p < 0.05) than the anterior

and posterior beams. Moreover, there is considerable

inter-patient differences in range uncertainties.

Figure 1. Median and inter-quartile range of the range

error ∆R in overshoot and undershoot at the beam’s

proximal and distal edge of the tumor respectively. The

angle of 90

is the lateral beam to the ipsilateral lung.

Conclusion

Variation in anatomy during the course of irradiation

causes variation in range, possibly leading to tumor under-

coverage and high dose in normal tissue. These range

uncertainties depend on patient and beam angle, and are

smaller for the lateral beams. Taking these beam-specific

range uncertainties into account, could improve the

robustness of proton treatment plan against anatomical

variations.

PO-0870 DIBH produces a meaningful reduction in lung

dose for some women with right-sided breast cancer

J.L. Conway

1

, L. Conroy

1

, L. Harper

1

, M. Scheifele

1

, W.

Smith

1

, T. Graham

1

, T. Phan

1

, H. Li

1

, I.A. Olivotto

1

1

Tom Baker Cancer Centre, Radiation Oncology, Calgary-

Alberta, Canada

Purpose or Objective

To determine whether deep inspiration breath hold (DIBH)

produced a clinically meaningful reduction in pulmonary

dose in comparison to free breathing (FB) during adjuvant

loco-regional radiation (RT) for right-sided breast cancer.

Subsequently, to prospectively evaluate DIBH in right-

sided breast cancer cases with a FB V20Gy ≥30%.

Material and Methods

Thirty consecutive women with breast cancer treated with

tangent pair RT following breast conserving surgery were

included. ESTRO guidelines were used to contour right-

sided IMC nodes on DIBH and FB scans, with care taken to

ensure comparability between scans. A four-field,

modified-wide tangent plan was developed on each scan

to include the right breast and full regional nodes with a

minimum dose of 80% to the IMC CTV. The junction

between the supraclavicular and tangent fields was at the

inferior extent of the ossified medial clavicle. Treatment

plans were calculated in Eclipse using Acuros algorithm

version 11. FB and DIBH plan metrics were compared using

Wilcoxon-signed rank testing. Commencing in March 2016,

as per a new institutional policy based on the above

results, all right-sided breast cancer patients with a FB

ipsilateral lung V20 ≥30% had a DIBH treatment plan

developed prior to compromising on IMC coverage. If the

absolute difference in lung V20 was ≥5% between plans,

the DIBH plan was used. The junction was moved

superiorly in only one case.

Results